Cargando…

Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis

INTRODUCTION: Active infective endocarditis is associated with high morbidity and mortality. Surgery is indicated in high-risk conditions, and the main determinants of mortality in surgical treatment should be evaluated. OBJECTIVE: To identify mortality predictors in the surgical treatment of active...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Jenny Lourdes Rivas, dos Santos, Magaly Arrais, Arnoni, Renato Tambellini, Ramos, Auristela, Togna, Dorival Della, Ghorayeb, Samira Kaissar, Kroll, Roberto Tadeu Magro, de Souza, Luiz Carlos Bento
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cirurgia Cardiovascular 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873776/
https://www.ncbi.nlm.nih.gov/pubmed/29617499
http://dx.doi.org/10.21470/1678-9741-2017-0132
_version_ 1783310055762821120
author de Oliveira, Jenny Lourdes Rivas
dos Santos, Magaly Arrais
Arnoni, Renato Tambellini
Ramos, Auristela
Togna, Dorival Della
Ghorayeb, Samira Kaissar
Kroll, Roberto Tadeu Magro
de Souza, Luiz Carlos Bento
author_facet de Oliveira, Jenny Lourdes Rivas
dos Santos, Magaly Arrais
Arnoni, Renato Tambellini
Ramos, Auristela
Togna, Dorival Della
Ghorayeb, Samira Kaissar
Kroll, Roberto Tadeu Magro
de Souza, Luiz Carlos Bento
author_sort de Oliveira, Jenny Lourdes Rivas
collection PubMed
description INTRODUCTION: Active infective endocarditis is associated with high morbidity and mortality. Surgery is indicated in high-risk conditions, and the main determinants of mortality in surgical treatment should be evaluated. OBJECTIVE: To identify mortality predictors in the surgical treatment of active infective endocarditis in a long-term follow-up. METHODS: This prospective observational study involved 88 consecutive patients diagnosed with active infective endocarditis, who underwent surgery between January 2005 and December 2015. Fifty-eight (65.9%) patients were male, the mean age was 50.87±16.15 years. A total of 31 (35.2%) patients had a history of rheumatic fever; 48 (54.5%) had had heart surgery with prosthetic valve implantation; 45 (93.8%) had biological prosthetic valve endocarditis and 3 (6.3%) mechanical prosthetic valve; 40 (45.5%) patients had the disease in their native valve. The mean EuroSCORE II was 8.9±6.5%, and the main surgical indication was refractory heart failure in 38 (43.2%) patients. A total of 68 bioprosthesis (36 aortic, 32 mitral) and 29 mechanical prostheses (12 aortic, 17 mitral) were implanted and three mitral valve plasties performed. A total of 25 (28.4%) patients underwent double or triple valve procedures. Aortic annulus reconstruction by abscess was performed in 18 (20.5%) and six (6.81%) patients had combined procedure. The mean surgery time was 359±97.6 minutes. RESULTS: The overall survival in up to a 10-year follow-up period was 79.5%. In the univariate analysis, the main mortality predictors were positive blood cultures (P=0.003), presence of typical microorganisms (P=0.008), most frequently Streptococcus viridans (12 cases; 25%); C-reactive protein (hazard ratio [HR] 1.034, 95% confidence interval [CI] 1.000 to 1.070, P=0.04); creatinine clearance (HR 0.977, 95% CI 0.962 to 0.993, P=0.005); length of surgery: every five minutes multiplies the chance of death 1.005-fold (HR 1.005, 95% CI 1.001 to 1.009, P=0.0307); age (HR 1.060, 95% CI 1.026 to 1.096, P=0.001); and EuroSCORE II (HR 1.089, 95% CI 1.030 to 1.151, P=0.003). CONCLUSION: A positive blood culture with typical microorganism, C-reactive protein, age, EuroSCORE II, total surgical time and the presence of postoperative complications were the major predictors of mortality and significantly impacted survival in up to a 10-year follow-up period.
format Online
Article
Text
id pubmed-5873776
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Cirurgia Cardiovascular
record_format MEDLINE/PubMed
spelling pubmed-58737762018-04-02 Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis de Oliveira, Jenny Lourdes Rivas dos Santos, Magaly Arrais Arnoni, Renato Tambellini Ramos, Auristela Togna, Dorival Della Ghorayeb, Samira Kaissar Kroll, Roberto Tadeu Magro de Souza, Luiz Carlos Bento Braz J Cardiovasc Surg Original Article INTRODUCTION: Active infective endocarditis is associated with high morbidity and mortality. Surgery is indicated in high-risk conditions, and the main determinants of mortality in surgical treatment should be evaluated. OBJECTIVE: To identify mortality predictors in the surgical treatment of active infective endocarditis in a long-term follow-up. METHODS: This prospective observational study involved 88 consecutive patients diagnosed with active infective endocarditis, who underwent surgery between January 2005 and December 2015. Fifty-eight (65.9%) patients were male, the mean age was 50.87±16.15 years. A total of 31 (35.2%) patients had a history of rheumatic fever; 48 (54.5%) had had heart surgery with prosthetic valve implantation; 45 (93.8%) had biological prosthetic valve endocarditis and 3 (6.3%) mechanical prosthetic valve; 40 (45.5%) patients had the disease in their native valve. The mean EuroSCORE II was 8.9±6.5%, and the main surgical indication was refractory heart failure in 38 (43.2%) patients. A total of 68 bioprosthesis (36 aortic, 32 mitral) and 29 mechanical prostheses (12 aortic, 17 mitral) were implanted and three mitral valve plasties performed. A total of 25 (28.4%) patients underwent double or triple valve procedures. Aortic annulus reconstruction by abscess was performed in 18 (20.5%) and six (6.81%) patients had combined procedure. The mean surgery time was 359±97.6 minutes. RESULTS: The overall survival in up to a 10-year follow-up period was 79.5%. In the univariate analysis, the main mortality predictors were positive blood cultures (P=0.003), presence of typical microorganisms (P=0.008), most frequently Streptococcus viridans (12 cases; 25%); C-reactive protein (hazard ratio [HR] 1.034, 95% confidence interval [CI] 1.000 to 1.070, P=0.04); creatinine clearance (HR 0.977, 95% CI 0.962 to 0.993, P=0.005); length of surgery: every five minutes multiplies the chance of death 1.005-fold (HR 1.005, 95% CI 1.001 to 1.009, P=0.0307); age (HR 1.060, 95% CI 1.026 to 1.096, P=0.001); and EuroSCORE II (HR 1.089, 95% CI 1.030 to 1.151, P=0.003). CONCLUSION: A positive blood culture with typical microorganism, C-reactive protein, age, EuroSCORE II, total surgical time and the presence of postoperative complications were the major predictors of mortality and significantly impacted survival in up to a 10-year follow-up period. Sociedade Brasileira de Cirurgia Cardiovascular 2018 /pmc/articles/PMC5873776/ /pubmed/29617499 http://dx.doi.org/10.21470/1678-9741-2017-0132 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
de Oliveira, Jenny Lourdes Rivas
dos Santos, Magaly Arrais
Arnoni, Renato Tambellini
Ramos, Auristela
Togna, Dorival Della
Ghorayeb, Samira Kaissar
Kroll, Roberto Tadeu Magro
de Souza, Luiz Carlos Bento
Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis
title Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis
title_full Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis
title_fullStr Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis
title_full_unstemmed Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis
title_short Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis
title_sort mortality predictors in the surgical treatment of active infective endocarditis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873776/
https://www.ncbi.nlm.nih.gov/pubmed/29617499
http://dx.doi.org/10.21470/1678-9741-2017-0132
work_keys_str_mv AT deoliveirajennylourdesrivas mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis
AT dossantosmagalyarrais mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis
AT arnonirenatotambellini mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis
AT ramosauristela mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis
AT tognadorivaldella mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis
AT ghorayebsamirakaissar mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis
AT krollrobertotadeumagro mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis
AT desouzaluizcarlosbento mortalitypredictorsinthesurgicaltreatmentofactiveinfectiveendocarditis